Exogenous expression of miR-21 and miR-630 enhanced PTX resistance of ovarian cancer cells by silencing apoptotic peptidase activating factor 1 (APAF1) (Au Yeung et al., 2016; Eoh et al., 2018). The gene discussed is APAF1; the disease is ovarian carcinoma.